Get the Stockscreener App
1.84
0.00%
0.00
Seer Inc stock is traded at $1.84, with a volume of 206.62K.
It is up +0.00% in the last 24 hours and down -5.64% over the past month.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.
See More
Previous Close:
$1.84
Open:
$1.86
24h Volume:
206.62K
Relative Volume:
1.47
Market Cap:
$103.50M
Revenue:
$14.18M
Net Income/Loss:
$-82.66M
P/E Ratio:
-1.4154
EPS:
-1.3
Net Cash Flow:
$-50.80M
1W Performance:
+2.79%
1M Performance:
-5.64%
6M Performance:
-10.68%
1Y Performance:
-15.98%
1-Day Range:
$1.80
$1.87
1-Week Range:
$1.79
$1.875
52-Week Range:
$1.62
$2.495
Seer Inc Stock (SEER) Company Profile
Name
Seer Inc
Sector
Industry
Phone
650-453-0000
Address
3800 BRIDGE PARKWAY, SUITE 102, REDWOOD CITY
Compare SEER with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SEER
Seer Inc
|
1.84 | 103.50M | 14.18M | -82.66M | -50.80M | -1.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.90 | 117.47B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
784.97 | 82.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.59 | 52.94B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
844.92 | 52.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.88 | 37.84B | 447.02M | -1.18B | -906.14M | -6.1812 |
Seer Inc Stock (SEER) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-05-23 | Resumed | JP Morgan | Neutral |
| Jan-04-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Aug-11-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Dec-29-20 | Initiated | BofA Securities | Neutral |
| Dec-29-20 | Initiated | Cowen | Outperform |
| Dec-29-20 | Initiated | JP Morgan | Overweight |
| Dec-29-20 | Initiated | Morgan Stanley | Equal-Weight |
View All
Seer Inc Stock (SEER) Latest News
We Think Seer (NASDAQ:SEER) Can Afford To Drive Business Growth - Yahoo Finance
Seer (SEER) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
How Seer Inc. stock performs after earningsJuly 2025 Rallies & Stock Market Timing Techniques - Улправда
Will Seer Inc. stock benefit from AI adoption2025 Historical Comparison & Technical Entry and Exit Alerts - Улправда
Can Seer Inc. stock deliver strong Q4 earningsJuly 2025 Drop Watch & Breakout Confirmation Alerts - Улправда
Why Seer Inc. stock could benefit from AI revolutionJuly 2025 Highlights & Target Return Focused Picks - Улправда
Seer to Report First Quarter 2025 Financial Results on May 13, 2025 - 富途牛牛
Why Seer Inc. stock is a must watch in 2025July 2025 Reactions & Verified Trade Idea Suggestions - DonanımHaber
Analyst Calls: Will Seer Inc. stock benefit from sector rotationEarnings Recap Report & Low Volatility Stock Recommendations - Улправда
What catalysts could drive Seer Inc. stock higherSell Signal & AI Driven Price Forecasts - DonanımHaber
Stock Market Recap: How Seer Inc. stock performs after earningsMarket Risk Report & Daily Entry Point Alerts - Улправда
Wall Street Recap: Why Seer Inc. stock could benefit from AI revolutionDividend Hike & Weekly Momentum Stock Picks - Улправда
Is Seer Inc. stock gaining market shareMarket Activity Summary & Advanced Technical Signal Analysis - Улправда
Insider Trends: Will Seer Inc. stock benefit from AI adoptionQuarterly Earnings Summary & Real-Time Buy Signal Notifications - Улправда
Retail Trends: Will Seer Inc. stock benefit from sector rotationJuly 2025 Momentum & Safe Capital Growth Stock Tips - Улправда
Aug Drivers: Is Seer Inc stock a buy before product launches2025 Winners & Losers & Community Verified Swing Trade Signals - moha.gov.vn
Wall Street Zen Upgrades Seer (NASDAQ:SEER) to Hold - MarketBeat
Seer (NASDAQ:SEER) Shares Down 2.8%Here's What Happened - MarketBeat
Seer (NASDAQ:SEER) Shares Down 2.8% – Here’s What Happened - Defense World
Seer (NASDAQ: SEER) ends dual-class shares as Class B converts to Class A - Stock Titan
Seer (NASDAQ: SEER) CEO details automatic Class B to Class A conversion - Stock Titan
Aug Retail: How buybacks impact Seer Inc stock valueMarket Growth Summary & Weekly High Return Stock Forecasts - moha.gov.vn
How Seer Inc. stock trades during market volatilityQuarterly Growth Report & Accurate Intraday Trading Signals - Newser
What drives Seer Inc stock priceStochastic Oscillator Alerts & Budget Friendly Trading Alerts - earlytimes.in
Nature Genetics Study Validates Seer’s Proteograph Platform as Essential for Turning Genetic Signals Into Reliable Drug Targets and Biomarkers - markets.businessinsider.com
Seer (SEER) Utilizes Proteograph Suite in Groundbreaking Genetic Study - GuruFocus
Seer, Inc. Publishes Landmark Genome-Wide Association Study Validating Mass Spectrometry Proteomics in Nature Genetics - Quiver Quantitative
Nature Genetics Study Validates Seer’s Proteograph Platform - GlobeNewswire
Aug Retail: Is Seer Inc. stock gaining market share2025 Price Targets & Scalable Portfolio Growth Methods - moha.gov.vn
Will Seer Inc. stock benefit from sector rotationWeekly Market Report & Entry Point Strategy Guides - moha.gov.vn
Seer, Inc. 2025 Q3ResultsEarnings Call Presentation (NASDAQ:SEER) 2025-11-26 - Seeking Alpha
What Makes Seer, Inc. (SEER) a Strong Momentum Stock: Buy Now? - MSN
Seer Inc Stock Analysis and ForecastPrice Support Zones & Free Trend Following Techniques - earlytimes.in
Pres Horn Surrenders 6,797 Of Seer Inc [SEER] - TradingView
[Form 4] Seer, Inc. Insider Trading Activity - Stock Titan
Seer at CG MedTech Forum: Proteomics Innovations Lead the Way - Investing.com India
Seer at CG MedTech Forum: Proteomics Innovations Lead the Way By Investing.com - Investing.com Canada
What insider trading reveals about Seer Inc. stockWeekly Investment Summary & High Conviction Buy Zone Alerts - newser.com
Key metrics from Seer Inc.’s quarterly data2025 Momentum Check & Smart Money Movement Tracker - newser.com
Can Seer Inc. stock sustain market leadershipQuarterly Earnings Report & High Conviction Buy Zone Alerts - newser.com
Predicting Seer Inc. trend using moving averages2025 Trading Recap & Technical Entry and Exit Alerts - newser.com
How Seer Inc. stock performs in stagflationGDP Growth & Weekly Market Pulse Alerts - newser.com
Should I hold or sell Seer Inc. stock in 2025Earnings Risk Summary & Long-Term Safe Return Strategies - newser.com
Does Seer Inc. stock trade at a discount to peersJuly 2025 News Drivers & Safe Entry Trade Signal Reports - newser.com
Why Seer Inc. stock is rated strong buy2025 Market WrapUp & Free Risk Controlled Daily Trade Plans - newser.com
Seer Inc Stock (SEER) Financials Data
Revenue
Net Income
Cash Flow
EPS
Seer Inc Stock (SEER) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Farokhzad Omid | CEO AND CHAIR |
Nov 19 '25 |
Sale |
1.97 |
33,838 |
66,708 |
1,238,230 |
| Horn David R. | PRESIDENT & CFO |
Aug 20 '25 |
Sale |
2.04 |
6,827 |
13,955 |
436,802 |
| Farokhzad Omid | CEO AND CHAIR |
Aug 20 '25 |
Sale |
2.04 |
33,992 |
69,483 |
1,272,068 |
| Nishar Dipchand | Director |
Jun 13 '25 |
Sale |
2.08 |
30,253 |
62,935 |
49,204 |
0.08%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):